EUVIMEDEUVIMED entdecken
Crossref

Synthesis of novel ciprofloxacin-avibactam conjugates for the development of second-generation non-β-lactam-β-lactamase inhibitors

Rahul Kumar, Vikas Pathania, Shashi Kumar, Mahender Kumar, Hemraj Nandanwar, Sushil K Maurya

Bioorganic & Medicinal Chemistry Letters · 2023

DOI: 10.1016/j.bmcl.2023.129308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2023. Verfasst von Rahul Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Technology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176061, India; Academy of Scientific and…. Hauptthemen laut MEDLINE: Ceftazidime, beta-Lactamase Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Academy of Scientific and Innovative Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To overcome the antibiotic resistance challenge, we synthesized a novel class of conjugates based on ciprofloxacin and avibactam, covalently linked by diverse amino acids. In vitro studies of these conjugates have shown improved antibacterial efficacy of avibactam when used alone against some ESKAPE pathogens, i.e., S. aureus, E. coli, and A. baumannii. Further, ceftazidime was screened in combination with all conjugates and found to be less synergistically effective than avibactam-ceftazidime co-dosing against K. pneumoniae and E. coli bacterial strains. Subsequently, the top-ranked active conjugates were investigated against the commercially available β-lactamase-II (Penicillinase from Bacillus cereus) through in vitro studies. These studies elucidated two conjugates i.e, 9 (IC50 = 1.69±0.35 nM) and 24b (IC50 = 57.37±5.39 nM), which have higher inhibition profile than avibactam (IC50 = 141.08±12.20 nM). These outcomes allude to avibactam integration with ciprofloxacin is a novel and fruitful approach to discovering clinically valuable next-generation non-β-lactam-β-lactamase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ceftazidimebeta-Lactamase InhibitorsCiprofloxacinLactamsEscherichia coliStaphylococcus aureusbeta-LactamasesAnti-Bacterial AgentsAzabicyclo CompoundsDrug CombinationsKlebsiella pneumoniaeMicrobial Sensitivity Tests

Stichwörter der Autor:innen

AvibactamCiprofloxacinConjugateGram-negative bacteriaNon-β-lactam-β-lactamase inhibitors

Substanzen

Ceftazidimebeta-Lactamase InhibitorsavibactamCiprofloxacinLactamsbeta-LactamasesAnti-Bacterial AgentsAzabicyclo CompoundsDrug Combinations

Autor:innen und Institutionen

  • Chemical Technology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176061, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India; Clinical Microbiology and Antimicrobial Research Laboratory, CSIR-Institute of Microbial Technology, Chandigarh 160036, India.
  • Chemical Technology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176061, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India; Department of C…

Förderung

  • Council of Scientific and Industrial Research, India
  • Academy of Scientific and Innovative Research

Zitieren

APA

Kumar, R., Pathania, V., Kumar, S., Kumar, M., Nandanwar, H., & Maurya, S. K. (2023). Synthesis of novel ciprofloxacin-avibactam conjugates for the development of second-generation non-β-lactam-β-lactamase inhibitors. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2023.129308

Vancouver

Kumar R, Pathania V, Kumar S, Kumar M, Nandanwar H, Maurya SK. Synthesis of novel ciprofloxacin-avibactam conjugates for the development of second-generation non-β-lactam-β-lactamase inhibitors. Bioorganic & Medicinal Chemistry Letters. 2023. doi:10.1016/j.bmcl.2023.129308

BibTeX
@article{Kumar2023,
  author = {Kumar, Rahul and Pathania, Vikas and Kumar, Shashi and Kumar, Mahender and Nandanwar, Hemraj and Maurya, Sushil K},
  title = {Synthesis of novel ciprofloxacin-avibactam conjugates for the development of second-generation non-β-lactam-β-lactamase inhibitors},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2023},
  doi = {10.1016/j.bmcl.2023.129308}
}
Kostenlos starten →